In association with
Logo Logo Logo

Hepatitis ‘B’ reaches to an alarming level in Dolpa, Western Nepal
-


DOLPA:- Seventy out of 343 patients examined in a health camp were diagnosed with hepatitis ‘B’ in Dolpobuddha rural municipality last year.
In the camp organized by Ek-Ek Paila Nepal, one was detected with HIV and three others were found with hepatitis ‘C’, shared Dr Melina Hamal, who proved health check-up service in the camp.
Immediately after the health camp, Bir Hospital’s senior lever specialist Dr Sudhamshu KC had shared that diagnosis of hepatitis ‘B’ among 30 percent of those examined at health camp was a serious indication from public health perspective.
He further said that the situation has come to an alarming point in lack of service of vaccination against hepatitis ‘B’ which needs to be inoculated immediately after the birth of a child.
Dr KC suggested the local governments to put in place massive public awareness on hepatitis ‘B’ to avert its dire consequences.
Doctors involved in the camp said that many people from Dho, Saldang, Bhijer, Chharka and Foksundo of upper Dolpa had tested positive for hepatitis ‘B’.

For Indian tourists travelling by land:- 72 hours (-ve) C-19 report, CCMC form and Antigen Test at entry point

For Indian tourists travelling by land:- 72 hours (-ve) C-19 report, CCMC form and Antigen Test at entry point

Comment here !
Related News

KATHMANDU:- Prime Minister Sher Bahadur Deuba and his Indian counterpart Narendra Modi are scheduled to meet next week. Both the

KATHMANDU:-Minister for Labor, Employment and Social Security Krishna Kumar Shrestha, who is currently in Dubai to attend the Sixth Ministerial-Level

KATHMANDU:- Vijaya Development Resource Center (VDRC-Nepal) – a social development organization – has handed over a child treatment ward to

N24 Correspondent, KATHMANDU: The meeting of the House of Representatives is being held today. The meeting is called at 2


Headlines
Information for Indian tourists travelling by land:- 72 hours (-) C-19 report, CCMC form and Antigen Test at entry point